Clinical Trials Browser

Phase 2 × Not yet recruiting × MSI-H Colorectal Cancer × Clear all

NCT05841134 2023-05-09

Tislelizumab Combined With Chemotherapy (CAPOX) in the Perioperative Treatment of MSI-H/dMMR Stage II or III Colorectal Cancer

Phase 2 Not yet recruiting

GastrointestinalOther solid neoplasm

MSI-H Colorectal Cancer